Press Release | Thu Oct 3, 2013 4:14pm EDT

Pfizer Inc. Announces FDA Approval of DUAVEE™ (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Ost

* Reuters is not responsible for the content in this press release.